Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study. // European Journal of Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S0959804926015480?dgcid=rss_sd_all
Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study. European Journal of Cancer. https://www.sciencedirect.com/science/article/pii/S0959804926015480?dgcid=rss_sd_all
“Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study.” European Journal of Cancer.
@article{article44998,
title = {Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study},
journal = {European Journal of Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S0959804926015480?dgcid=rss_sd_all}
}